IGC Pharma (IGC) Debt to Equity (2011 - 2026)

IGC Pharma (IGC) reported Debt to Equity of $0.04 for Q1 2026, up 68.24% year-over-year from $0.02 in Q1 2025, and down 46.16% quarter-over-quarter from $0.07 in Q4 2025.

IGC Pharma (IGC) Debt to Equity (2011 - 2026) Analysis & Trends

IGC Pharma (IGC) has 16 years of Debt to Equity data on file, last reported at $0.04 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at $0.04, up 68.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.04 (up 68.24% YoY), and the FY2026 annual result was $0.04, up 68.24% from the prior year.
  • Debt to Equity retreated to $0.04 in Q1 2026 per IGC's latest filing, from $0.07 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.07 in Q4 2025 and troughed at $0.01 in Q1 2022.
  • A 5-year average of $0.02 and a median of $0.02 in 2025 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2022 and 2025: Debt to Equity plunged 65.2% in 2022, then jumped 208.96% in 2025.
  • A 5-year view of Debt to Equity shows it stood at $0.01 in 2022, then jumped by 98.03% to $0.02 in 2023, then soared by 40.45% to $0.02 in 2024, then jumped by 208.96% to $0.07 in 2025, then slumped by 46.16% to $0.04 in 2026.
  • Business Quant data shows IGC's Debt to Equity at $0.04 in Q1 2026, $0.07 in Q4 2025, and $0.02 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 IGC Pharma 29.33 Mn 29.07 Mn - 0.04

Historic Data

Download Data
DateValue
Mar 31, 2026 0.04
Dec 31, 2025 0.07
Sep 30, 2025 0.02
Jun 30, 2025 0.02
Mar 31, 2025 0.02
Dec 31, 2024 0.02
Sep 30, 2024 0.02
Jun 30, 2024 0.02
Mar 31, 2024 0.02
Dec 31, 2023 0.02
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.00
Jun 30, 2021 0.00